Concepedia

Karen Nalbandyan

KN

Statistics

Publications

8

Citations

183

H-Index

8

Active since

2012

Affiliations

Ben-Gurion University of the Negev(Current)

Tel Aviv University

Soroka Medical Center

Hebrew University of Jerusalem

Karen Nalbandyan is an author at Ben-Gurion University of the Negev specializing in medicine, oncology, and cancer pharmacology.

ORCID

Publications per year

2012–2022

8

Publications

8

Dimethyl fumarate and vitamin D derivatives cooperatively enhance VDR and Nrf2 signaling in differentiating AML cells in vitro and inhibit leukemia progression in a xenograft mouse model

Matan Nachliely, Aviram Trachtenberg, Boris Khalfin et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2018 · 52 citations

, , +15

Cell surface GRP78: A potential marker of good prognosis and response to chemotherapy in breast cancer

Rinat Yerushalmi, Annat Raiter, Karen Nalbandyan et al. · Oncology Letters · 2015 · 35 citations · Full text

, , +16

Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes

Rami Yossef, Chamutal Gur, Avishai Shemesh et al. · PLoS ONE · 2015 · 25 citations · Full text

, , +17

CD20 Over-Expression in Hodgkin-Reed-Sternberg Cells of Classical Hodgkin Lymphoma: the Neglected Quest

Daniel Benharroch, Karen Nalbandyan, Irina Lazarev · Journal of Cancer · 2015 · 19 citations · Full text

, , +14

Management of gastrosplenic fistula in the emergency setting - A case report and review of the literature

Amit Frenkel, Yoav Bichovsky, Zvi Perry et al. · Annals of Medicine and Surgery · 2018 · 16 citations · Full text

, , +13

1–5 of 8